Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers

BACKGROUND: The purpose of this study was to test whether immunohistochemical (IHC) Ki67 levels after short-term preoperative hormone therapy (post-Ki67) predict similar numbers of patients with favorable prognoses as genomic markers. RESULTS: Thirty paired cases (60 samples) were enrolled in this s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Iwamoto, Takayuki, Katagiri, Toyomasa, Niikura, Naoki, Miyoshi, Yuichiro, Kochi, Mariko, Nogami, Tomohiro, Shien, Tadahiko, Motoki, Takayuki, Taira, Naruto, Omori, Masako, Tokuda, Yutaka, Fujiwara, Toshiyoshi, Doihara, Hiroyoshi, Gyorffy, Balazs, Matsuoka, Junji
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5432244/
https://ncbi.nlm.nih.gov/pubmed/28412725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15385
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items